Dysregulated PAD4 activity has been implicated in several autoimmune and inflammatory diseases, including type 1 diabetes mellitus (T1DM), rheumatoid arthritis, and systemic lupus erythematosus [1,2,3]. Here, PADI4 is linked to diabetes mellitus.